This inventor holds 1 USPTO granted patent. Top assignee: Norwich Eaton Pharmaceuticals, Inc.. Active years: 1986.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1986
Title: Frank F. Ebetino and His Tumor-Treatment Patent.
Introduction
Frank F. Ebetino is an inventor associated with Norwich, New York. His patent work includes a composition proposed for treating certain malignant tumors.
Latest Patents
The supplied information identifies one patent for Ebetino: “Compositions for Treating Tumors.” The invention concerns compositions containing ethyl 4-hydroxy-2-[(5-morpholinomethyl-2-oxo)-3-oxazolidinyliminomethyl]furo[2,3-b]pyridine-5-carboxylate, referred to as Compound I, or its pharmaceutically acceptable salts or hydrates. The patent describes these compositions as useful for treating certain malignant tumors. Ebetino’s reported total is 1 patent.
Career Highlights
Ebetino is associated with Norwich Eaton Pharmaceuticals, Inc. The tumor-treatment composition represents the patent contribution described in the information provided.
Collaborations
Homer A. Burch is identified as Ebetino’s coworker. The supplied information does not specify their roles in developing or patenting the composition.
Conclusion
Frank F. Ebetino’s documented patent work centers on a pharmaceutical composition intended for treating certain malignant tumors, developed in connection with Norwich Eaton Pharmaceuticals, Inc.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile